SARS-CoV-2血清学检测敏感性的动态变化:系统综述与建模研究
该研究对SARS-CoV-2血清学研究进行系统综述与荟萃分析,纳入检测既往确诊、未接种疫苗个体的研究,排除高度不能代表一般人群的队列。共筛查488项研究,最终纳入76项研究、涉及50种不同血清学检测;敏感性衰减强烈依赖检测所用抗原与分析技术,感染后6个月平均敏感性依检测特征介于26%至98%,三分之一的检测在6个月后明显偏离制造商规格。
要点
- 感染后6个月平均敏感性依检测特征介于26%至98%。
- 敏感性衰减强烈依赖检测所用抗原与分析技术。
- 三分之一的纳入检测在6个月后明显偏离制造商规格。
核心结论
- 血清学检测敏感性衰减取决于检测特征,对某些类型检测可使制造商规格高度不可靠。
- 作者提供工具用于校正该现象并评估特定检测的衰减风险。
- 该分析可指导SARS-CoV-2及其他病原体血清学调查的设计与解读,并量化现有血清学文献中的系统偏倚。
研究设计与样本
- 系统综述与荟萃分析,纳入检测既往确诊、未接种疫苗个体的SARS-CoV-2血清学研究。
- 排除高度不能代表一般人群的队列(如住院患者)。
- 筛查488项研究,最终纳入76项研究,涉及50种不同血清学检测。
主要发现
- 敏感性衰减强烈依赖检测所用抗原与分析技术。
- 感染后6个月平均敏感性依检测特征介于26%至98%。
- 三分之一的纳入检测在6个月后明显偏离制造商规格。
临床怎么用
- 作者提供工具用于校正血清学检测敏感性随时间衰减的现象,并评估特定检测的衰减风险。
- 作者认为该分析可指导SARS-CoV-2及其他病原体血清学调查的设计与解读,并量化现有血清学文献中的系统偏倚。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BackgroundSerological surveys have been the gold standard to estimate numbers of SARS-CoV-2 infections, the dynamics of the epidemic, and disease severity. Serological assays have decaying sensitivity with time that can bias their results, but there is a lack of guidelines to account for this phenomenon for SARS-CoV-2.AimOur goal was to assess the sensitivity decay of seroassays for detecting SARS-CoV-2 infections, the dependence of this decay on assay characteristics, and to provide a simple method to correct for this phenomenon.MethodsWe performed a systematic review and meta-analysis of SARS-CoV-2 serology studies. We included studies testing previously diagnosed, unvaccinated individuals, and excluded studies of cohorts highly unrepresentative of the general population (e.g. hospitalised patients).ResultsOf the 488 screened studies, 76 studies reporting on 50 different seroassays were included in the analysis. Sensitivity decay depended strongly on the antigen and the analytic technique used by the assay, with average sensitivities ranging between 26% and 98% at 6 months after infection, depending on assay characteristics. We found that a third of the included assays departed considerably from manufacturer specifications after 6 months.ConclusionsSeroassay sensitivity decay depends on assay characteristics, and for some types of assays, it can make manufacturer specifications highly unreliable. We provide a tool to correct for this phenomenon and to assess the risk of decay for a given assay. Our analysis can guide the design and interpretation of serosurveys for SARS-CoV-2 and other pathogens and quantify systematic biases in the existing serology literature.
引用
- Owusu-Boaitey N, Russell TW, Meyerowitz-Katz G, et al. Dynamics of SARS-CoV-2 seroassay sensitivity: a systematic review and modelling study. Euro Surveill. 2023. PMID: 37227301. doi:10.2807/1560-7917.ES.2023.28.21.2200809
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。